跳至主要内容
临床试验/ACTRN12621001280897
ACTRN12621001280897尚未招募未知

A clinical trial examining the effects of SingINg For breathing on quality of life in COPD aNd ILD pAtients

St Vincents Hospital Melbourne0 个研究点目标入组 140 人开始时间: 2021年9月22日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patient Cohort:
  • 1.Participants with a confirmed diagnosis of COPD or ILD
  • Diagnosis confirmed on either CT chest scan (within the last 5 years) or lung function testing (within the last 2 years)
  • 2.On stable treatment for at least 4 weeks
  • Has not started any new or changed existing cardiorespiratory medications (including antibiotics and oral steroids). To be determined by study site clinician.
  • Has not been admitted to hospital with an exacerbations of their underlying disease (COPD or ILD) within the past 4 weeks.
  • 3.Modified Medical Research Council dyspnoea score grerater than or equal to 2
  • 4.Aged 18 years or over
  • 5.Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.
  • Carers Cohort (optional):
  • 1.Nominated carers of eligible patients will be eligible to participate.
  • 2.Aged 18 years or over
  • 3.Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.

排除标准

  • 1.Participants cannot be actively undertaking a centre-based pulmonary rehabilitation program. However past completion of such a program is permitted.

研究者

发起方
St Vincents Hospital Melbourne

相似试验